Quantum-Si Inc

Quantum-Si Inc(QSI)の株式分析

$0.780

-0.022 (-2.88%)終値時点

Loading chart…
High
0.822
Open
0.822
VWAP
0.79
Vol
2.42M
Mkt Cap
133.31M
Low
0.770
Amount
1.91M
EV/EBITDA, TTM
-0.36

Quantum-SI Incorporated is a life sciences company. The Company has designed and developed a hardware, consumable and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins. Its launched product consists of Platinum, the Platinum Analysis Software and consumables. Its flagship protein sequencing instrument, Platinum, is designed to make the power of single-molecule detection and NGPS accessible. Platinum is designed to provide a streamlined workflow compared to legacy MS workflows. Platinum uses its proprietary semiconductor chip that leverages time-domain sequencing with an initial focus on NGPS for an unbiased view of the proteome.

AI analysis of Quantum-Si Inc (QSI)

hold

Quantum-Si Inc is currently not a strong buy due to ongoing financial losses and insider selling, despite a potential upside in the long term.

バリュエーション指標

The current forward P/E ratio for Quantum-Si Inc (QSI) is 0.00, compared to its 5-year average forward P/E of -3.49.

Forward P/E

Overvalued
5Y Average P/E
-3.49
Current P/E
0.00
割高
-1.08
割安
-5.90

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
-0.63
Current EV/EBITDA
-0.36
割高
1.00
割安
-2.26

Forward P/S

Fair
5Y Average P/S
77.23
Current P/S
30.32
割高
167.56
割安
-13.11

Alphio AI Price Scenarios for QSI

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%QSI

$4.58

シナリオ価格

B

Base

Base · 50%QSI

$3.98

シナリオ価格

B

Bear

Bear · 25%QSI

$3.82

シナリオ価格

イベントタイムライン

2026-05-21 (ET)

08:50:00

Kodiak AI Borrow Rate Increases to 210.02%

2026-05-07 (ET)

16:50:00

Proteus Reports Q1 Revenue of $258K, Below Consensus

2026-04-28 (ET)

08:40:00

Quantum-Si Achieves Sequencing on Integrated Proteus Instruments

2026-04-14 (ET)

08:40:00

Quantum-Si Releases New Study on Human Cohesin Function in Yeast

2026-04-08 (ET)

09:20:00

Quantum-Si Completes Sequencing on Proteus Prototype System

ニュース

QSI FAQ — answered by Alphio AI

Quantum-SI Incorporated is a life sciences company. The Company has designed and developed a hardware, consumable and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins. Its launched product consists of Platinum, the Platinum Analysis Software and consumables. Its flagship protein sequencing instrument, Platinum, is designed to make the power of single-molecule detection and NGPS accessible. Platinum is designed to provide a streamlined workflow compared to legacy MS workflows. Platinum uses its proprietary semiconductor chip that leverages time-domain sequencing with an initial focus on NGPS for an unbiased view of the proteome. It operates in the Healthcare sector (MEASURING & CONTROLLING DEVICES, NEC industry).

Quantum-Si Inc is currently not a strong buy due to ongoing financial losses and insider selling, despite a potential upside in the long term.

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

無料で始める